Donepezil increases resistance to induced seizures in a mouse model of Dravet syndrome
Abstract De novo loss‐of‐function mutations in SCN1A are the main cause of Dravet syndrome, a catastrophic encephalopathy characterized by recurrent early‐life febrile seizures, a number of other afebrile seizure types that are often refractory to treatment, and behavioral abnormalities including so...
Main Authors: | Jennifer C. Wong, Jacquelyn T. Thelin, Andrew Escayg |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2019-08-01
|
Series: | Annals of Clinical and Translational Neurology |
Online Access: | https://doi.org/10.1002/acn3.50848 |
Similar Items
-
Perampanel Reduces Hyperthermia-Induced Seizures in Dravet Syndrome Mouse Model
by: Shih-Yin Ho, et al.
Published: (2021-07-01) -
Nanoparticle encapsulated oxytocin increases resistance to induced seizures and restores social behavior in Scn1a-derived epilepsy
by: Jennifer C. Wong, et al.
Published: (2021-01-01) -
Seizure reduction with fluoxetine in an adult woman with Dravet syndrome
by: Kimford J. Meador
Published: (2014-01-01) -
Preclinical Animal Models for Dravet Syndrome: Seizure Phenotypes, Comorbidities and Drug Screening
by: Aliesha Griffin, et al.
Published: (2018-06-01) -
Disordered breathing in a mouse model of Dravet syndrome
by: Fu-Shan Kuo, et al.
Published: (2019-04-01)